Literature DB >> 19023163

Vascular type of Ehlers-Danlos syndrome.

Atsushi Watanabe1, Takashi Shimada.   

Abstract

Vascular type of Ehlers-Danlos syndrome (EDS), also known as EDS type IV (NIM#130050) is a life-threatening autosomal dominant inherited disorder of connective tissue, caused by mutations of the COL3A1 gene. Vascular EDS causes severe fragility of connective tissues with arterial and intestinal ruptures and complications of surgical and radiological treatment, and is of particular importance to medical professionals of many specialties: surgeons, internists, radiologists, and obstetricians. An accurate diagnosis may help in the management of visceral complications. In addition, when a family is faced with new information concerning a positive genetic test for vascular EDS, it is crucial that follow-up care for the family include comprehensive genetic counseling. After the genetic diagnosis of a COL3A1 mutation, various medical specialists, including the clinical geneticists must cooperate to perform genetic counseling and to provide a system of long-term follow up for individuals with vascular EDS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023163     DOI: 10.1272/jnms.75.254

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  12 in total

1.  The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.

Authors:  T K Cooper; Q Zhong; M Krawczyk; H-J Tae; G A Müller; R Schubert; L A Myers; H C Dietz; M I Talan; W Briest
Journal:  Vet Pathol       Date:  2010-06-29       Impact factor: 2.221

Review 2.  The Genetics of Pneumothorax.

Authors:  Philip M Boone; Rachel M Scott; Stefan J Marciniak; Elizabeth P Henske; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

3.  Chronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.

Authors:  Hyun-Jin Tae; Shannon Marshall; Jing Zhang; Mingyi Wang; Wilfried Briest; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2012-07-19       Impact factor: 4.030

4.  Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts.

Authors:  Gerd A Müller; Uwe Hansen; Zhi Xu; Benjamin Griswold; Mark I Talan; Nazli B McDonnell; Wilfried Briest
Journal:  FASEB J       Date:  2011-10-28       Impact factor: 5.191

5.  Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome.

Authors:  Wilfried Briest; Timothy K Cooper; Hyun-Jin Tae; Melissa Krawczyk; Nazli B McDonnell; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

6.  Conservative management of small bowel perforation in Ehlers-Danlos syndrome type IV.

Authors:  Satya Allaparthi; Himanshu Verma; David L Burns; Ann M Joyce
Journal:  World J Gastrointest Endosc       Date:  2013-08-16

7.  Sigmoid colon perforation induced by the vascular type of Ehlers-Danlos syndrome: report of a case.

Authors:  Hiroshi Omori; Atsushi Hatamochi; Makoto Koike; Yoshitoshi Sato; Tomoki Kosho; Yasuhito Kitakado; Takafumi Oe; Toshiki Mukai; Yoko Hari; Yoshifumi Takahashi; Kenji Takubo
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

8.  An autosomal recessive leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis pigmentosa maps to chromosome 17q24.2-25.3.

Authors:  Ahmed Bouhouche; Ali Benomar; Leila Errguig; Lamiae Lachhab; Naima Bouslam; Jehanne Aasfara; Sanaa Sefiani; Layachi Chabraoui; Elmostafa El Fahime; Abdeljalil El Quessar; Mohamed Jiddane; Mohamed Yahyaoui
Journal:  BMC Med Genet       Date:  2012-03-21       Impact factor: 2.103

9.  Transvenous embolization for carotid-cavernous fistula in a patient with vascular type of Ehlers-Danlos syndrome--direct superior ophthalmic vein approach: case report.

Authors:  Teppei Tanaka; Motoharu Hayakawa; Akiyo Sadato; Kazuhide Adachi; Takeya Watabe; Shingo Maeda; Masahiro Ohmura; Yuichi Hirose
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-01-10       Impact factor: 1.742

10.  Vascular-type Ehlers-Danlos syndrome caused by a hitherto unknown genetic mutation: a case report.

Authors:  Fumihiro Kashizaki; Atsushi Hatamochi; Kazunori Kamiya; Akira Yoshizu; Hiroaki Okamoto
Journal:  J Med Case Rep       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.